Drugs / ZH9PA
last change Feb 2021 re-read 3 minutes ago

ZH9PA

Developed for
bacterial infectious disease
Investigated by
Prokarium Ltd · Simbec Research

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04349553 Dec 2019 → Sep 2020 bacterial infectious disease Prokarium Ltd Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ZH9PA ClinicalTrials.gov intervention name — accepted as the source's own label NCT04349553 ↗